There was a tragedy in France recently that did not
involve offensive cartoons, radicalized jihadists or terrorists masquerading as
refugees. Innocent French citizens were
taken down by a profession whose mission is to heal and comfort. A medical clinical trial careened off the
rails and crashed. Were these volunteer
study patients properly informed? Are
medical study patients here in the U.S. truly making a free choice?
From time to time, friends, patients and relatives ask my
advice if they should participate in a medical experiment. While I am a doctor, I usually say no. And, once I explain to them the realities of medical
research, they usually say no also.
While my colleagues may chastise me for not encouraging my
patients to join clinical trials, my primary obligation is to advocate for the
patient before me, not for society. If physicians
contemplate changing this ethical construct to consider the greater good when
we advise patients, then we need to engage the public in a serious conversation
on this issue.
Warning! Medical Research Zone
When an individual joins a research project, the medical
study is not designed to benefit the individual patient. This point is sorely misunderstood by patients
and their families who understandably will pursue any opportunity to help an
ailing relative. I get this. I wonder, however, how many of them would
sign up if they knew that they would be unlikely to personally benefit.
There are three powerful conspiring forces that may exert
undue influence on prospective study patients.
- Medical research needs a steady diet of new study recruits. In other words, the beast must be fed.
- Medical investigators often have biases favoring their research and truly believe that the new drug or treatment has a real chance of helping study patients. Phrasing such as ‘preliminary results are quite promising’ may be well intentioned, but may be beyond the facts.
- Patients, particularly those who are not responding to conventional treatment, are vulnerable.
Here’s the truth. Medical
research projects and clinical trials are designed to generate new knowledge
that will be used to help patients down the road, not those in the study. Of course, I cannot assert that a study
patient won’t realize a favorable result, but this serendipitous outcome is not
the study’s planned yield.
Beware of the packaging.
If your mom or dad has Alzheimer’s disease, of course, you would be
susceptible to the following pitch.
Is someone you love
struggling against Alzheimer’s disease?
Our Neurological Institute has been fighting hard against Alzheimer’s
disease and is now testing a new drug to help conserve memory. Call for confidential information. Doesn’t this wording suggest direct
benefit toward volunteers? Are study
participants, in fact, facing risks without benefit?
I strongly support medical research which is our source of future
cures and treatments. The medicines and treatments that we use today are the
result of years of research done years ago.
We need to generously fund our respected research institutions. But, we must ensure that the research
community adheres to the highest ethical standards, and that any breaches are
exposed and remedied. There’s a reason
that the term informed consent
contains the word informed. Uninformed
or misinformed consent can’t be
tolerated.
In France, 90 volunteers were in a study testing the safety
of a psychiatric medication. One is dead and others have suffered irreversible brain damage. While a horrible outcome is not tantamount to
guilt, this is a deeply disturbing event that must be investigated. We will find out soon enough if the French
study subjects were given all the information they were entitled to, and if
investigators and others behaved properly.
Even if no lapses are discovered, it will underscore that experimental
treatment has unknown risks, which may be devastating. In other words, investigators may be unaware
of the full extent of a study’s risks.
Hence, patients aren’t fully aware either.
If you want to join a medical study to serve humanity – and
not yourself – then you are free to make this informed choice, and I applaud
your decision. Helping others is a
praiseworthy act. So is telling the
truth.
This piece previously published on www.cleveland.com
Much of what you point out relating to clinical trials also applies to clinical practice, especially the informed consent aspects.
ReplyDelete